Previous close | 2.0300 |
Open | 2.0500 |
Bid | 2.0200 x 200 |
Ask | 2.1000 x 200 |
Day's range | 1.9100 - 2.1700 |
52-week range | 1.0500 - 4.1900 |
Volume | |
Avg. volume | 242,017 |
Market cap | 130.107M |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.5600 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.88 |
Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) shareholders (or potential shareholders) will be happy to see that the...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript May 6, 2024 Corvus Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon ladies and gentlemen and welcome to the Corvus Pharmaceuticals’ Business Update and Reports First Quarter […]
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call